Integrated Whole-Genome Analysis of Hematologic Disorders

Status Completed

Clinical Trial Summary

We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hematologic Diseases

Clinical Trial Details

NCT number	NCT01108159
Study type	Observational
Source	Stanford University
Contact
Status	Completed
Phase
Start date	September 2009
Completion date	August 2, 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04094844` - Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation	N/A
Completed	`NCT04474678` - Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")	N/A
Recruiting	`NCT03918343` - Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation	N/A
Completed	`NCT01445561` - Ultra Low Dose Interleukin-2 in Healthy Volunteers	Phase 1
Recruiting	`NCT06148610` - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed	`NCT04168983` - Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy	N/A
Not yet recruiting	`NCT05969821` - Clonal Hematopoiesis of Immunological Significance
Withdrawn	`NCT04282174` - CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies	Phase 2
Completed	`NCT00800839` - Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide	Phase 2
Completed	`NCT00213239` - A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children	Phase 1/Phase 2
Terminated	`NCT00208949` - A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF	Phase 2
Terminated	`NCT00176826` - T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders	Phase 2/Phase 3
Completed	`NCT00208962` - Allogeneic Cell Therapy for Adults With Hematologic Malignancies	Phase 2
Completed	`NCT00000603` - Cord Blood Stem Cell Transplantation Study (COBLT)	Phase 2
Completed	`NCT00000587` - Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection	Phase 2
Active, not recruiting	`NCT03655678` - A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia	Phase 2/Phase 3
Recruiting	`NCT05487794` - Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis	N/A
Completed	`NCT03611257` - Effect of dRAST on Treatment for Bacteremia in Patients With Hematologic Diseases	N/A
Completed	`NCT02827149` - High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT
Completed	`NCT04584528` - Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease	N/A